Literature DB >> 21504949

Developmental regulation of P-glycoprotein activity within thymocytes results in increased anti-HIV protease inhibitor activity.

Soichi Haraguchi1, Sarah K Ho, Matthew Morrow, Maureen M Goodenow, John W Sleasman.   

Abstract

The thymus harbors HIV-1 and supports its replication. Treatment with PI-containing ART restores thymic output of naïve T cells. This study demonstrates that CXCR4-using WT viruses are more sensitive to PI in fetal thymcocytes than mature T cells with average IC(50) values for two PIs, RTV and IDV, of 1.5 nM (RTV) and 4.4 nM (IDV) in thymocytes versus 309.4 nM (RTV) and 27.3 nM (IDV) in mature T cells. P-gp activity, as measured using Rh123 efflux and quantitation of P-gp mRNA, increased with thymocyte maturation into CD4 and CD8 lineage T cells. P-gp activity is developmentally regulated in the thymus. Thymocytes developed increased levels of P-gp activity as maturation from DP to SP CD4 or CD8 T cells occurred, although CD4 T cells acquired activity more rapidly. Reduced P-gp activity in thymocytes is one mechanism for effectiveness of PI therapy in suppressing viral replication in the thymus and in reconstitution of naïve T cells, particularly among children receiving PI-containing ART.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21504949      PMCID: PMC3409632          DOI: 10.1189/jlb.0111-009

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  52 in total

1.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells.

Authors:  A S Chong; P N Markham; H M Gebel; S D Bines; J S Coon
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

3.  Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4.

Authors:  Andrew Owen; Becky Chandler; Patrick G Bray; Stephen A Ward; C Anthony Hart; David J Back; Saye H Khoo
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  P-glycoprotein expression and function in circulating blood cells from normal volunteers.

Authors:  W T Klimecki; B W Futscher; T M Grogan; W S Dalton
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

5.  Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.

Authors:  D Drach; S Zhao; J Drach; R Mahadevia; C Gattringer; H Huber; M Andreeff
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

6.  Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function.

Authors:  S Gupta; C H Kim; T Tsuruo; S Gollapudi
Journal:  J Clin Immunol       Date:  1992-11       Impact factor: 8.317

7.  Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.

Authors:  P M Chaudhary; E B Mechetner; I B Roninson
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

8.  The SCID-hu mouse as a model for HIV-1 infection.

Authors:  G M Aldrovandi; G Feuer; L Gao; B Jamieson; M Kristeva; I S Chen; J A Zack
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

9.  Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: modulation with differentiation stage and during aging.

Authors:  L M Pilarski; D Paine; J E McElhaney; C E Cass; A R Belch
Journal:  Am J Hematol       Date:  1995-08       Impact factor: 10.047

10.  Structure-activity relationship of verapamil analogs and reversal of multidrug resistance.

Authors:  G Toffoli; F Simone; G Corona; M Raschack; B Cappelletto; M Gigante; M Boiocchi
Journal:  Biochem Pharmacol       Date:  1995-10-12       Impact factor: 5.858

View more
  5 in total

Review 1.  Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Authors:  Minlu Hu; Sravan Kumar Patel; Tian Zhou; Lisa C Rohan
Journal:  J Control Release       Date:  2015-08-13       Impact factor: 9.776

Review 2.  Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.

Authors:  Suzi Hong; William A Banks
Journal:  Brain Behav Immun       Date:  2014-10-22       Impact factor: 7.217

Review 3.  Pharmacology of HIV Cure: Site of Action.

Authors:  Aaron S Devanathan; Mackenzie L Cottrell
Journal:  Clin Pharmacol Ther       Date:  2021-03-05       Impact factor: 6.875

Review 4.  P-glycoprotein and drug resistance in systemic autoimmune diseases.

Authors:  Andrea Picchianti-Diamanti; Maria Manuela Rosado; Marco Scarsella; Bruno Laganà; Raffaele D'Amelio
Journal:  Int J Mol Sci       Date:  2014-03-20       Impact factor: 5.923

5.  P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.

Authors:  Gerard Minuesa; Cristina Arimany-Nardi; Itziar Erkizia; Samandhy Cedeño; José Moltó; Bonaventura Clotet; Marçal Pastor-Anglada; Javier Martinez-Picado
Journal:  J Antimicrob Chemother       Date:  2016-06-21       Impact factor: 5.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.